Alcon Inc. (ACL)


Alcon, Inc. is the world’s leading eye care company, with sales of $5.6 billion in 2007. Alcon, which has been dedicated to the ophthalmic industry for more than 60 years, researches, develops, manufactures and markets pharmaceuticals, surgical equipment and devices, contact lens care solutions and other vision care products that treat diseases, disorders and other conditions of the eye. Alcon’s majority shareholder is Nestlé, S.A., the world’s largest food company. Moxifloxacin, the active ingredient in Vigamox®, is licensed to Alcon from Bayer AG. Ciprodex® is a registered trademark of Bayer AG and licensed to Alcon, Inc. by Bayer Healthcare AG.

Contact Information

Bosch 69
PO Box 62
Hunenberg, 6331

tel: 41 41 785 88 88
fax: 41 41 785 88 87


Investor Relations



Exchange: NYSE
Industry: Medical Instruments & Supplies
Market Cap: $45.4B

The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases. Please see our Disclaimer and Terms of Service for more information.